Wow - this stock has taken a severe beating over the past several months - got hit hard today. Now it is in a really attractive buy range (around $20/share). This stock is or was one of the golden childs of the stock market until it got slammed a couple of months back and again today. But take a look at the earnings growth and revenue growth and you will quickly see that this is prime time to buy. Yes, perhaps it will dip below $20 for a while, perhaps as low as $18.50. But when you look at the upside, this has a high possibility of doubling in 1 year.  I am expecting it to hang in the low 20's for the remainder of the year. If the 4th quarter is not as bad as expected, then you could see this stock skyrocket in early 2008. Keep in mind that the eye surgery is an elective surgery typically not covered by insurance, so most people will use a flexible spending account for this - some people will have money they need to spend at the end of the year, but most will add money for 2008 to cover this procedure - so don't expect anything substantial in 2007, but the end of 2008 1st quarter will bring gold at the end of the rainbow and a renewed interest in the stock. When considering the time value of money, remember they pay a dividend.

Most notable about the stock - got crushed near the end of 2nd quarter. 3rd quarter revenues surged 88% and it got crushed again.

July 2008 target price by the Boop Investor: $37.50